Clinics I work with
My reviews
5.0
Dr Clarke has been an amazing care provider that I not only would recommend but look forward to her care for the rest of my life.
Selected research
-
Current Advances in Immunotherapy for Glioblastoma.
Current oncology reports
-
Randomized phase II and biomarker study of pembrolizumab plus bevacizumab versus pembrolizumab alone for recurrent glioblastoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research
-
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.
Neuro-oncology advances
Clinical trials
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenoty...
patients with stable disease will be considered responders if disease is stable for 27 weeks or more. The regimen will be considered worthy of further study if responses as defined above are observed in at least 3 of the 12 subjec...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2966